BioSpace News Archive

International Consensus Statement on Postoperative Anemia Management Recommends Noninvasive Hemoglobin Measurement Including Masimo SpHb®

Masimo announced today that a new consensus statement on postoperative anemia management was published in Anaesthesia by an international panel of clinicians specializing in patient blood management, which includes clear guidance on the use and benefits of noninvasive hemoglobin measurement.1

November 12, 2018
·
9 min read
Drug Development

The First Pellino-1 Inhibitor BBT-401 Confirms Its Safety and Tolerability from the Phase I Study

Bridge Biotherapeutics Inc. announced that BBT-401, the first anti-Pellino-1 compound currently under development for ulcerative colitis (UC) treatment, proved its safety and tolerability from phase I study.

November 12, 2018
·
2 min read
HDBaseT Alliance Establishes Medical Work Group to Address the AV Needs of the Healthcare Sector

The HDBaseT Alliance, the cross-industry group tasked with promoting and advancing the HDBaseT standard, is pleased to announce the establishment of the Medical Work Group to develop an industry standard for secure medical connectivity.

November 12, 2018
·
3 min read
Genetown

Synlogic Presents Data at the 2018 Liver Meeting, the Annual Meeting of the American Association for the Study of Liver Disease (AASLD)

- Data support ongoing evaluation of Synthetic BioticTM SYNB1020 for the potential treatment of hyperammonemia -

November 12, 2018
·
7 min read
Business

The Maui High-Performance Computing Center and the University of Manchester Join the OpenMP Effort

33 vendors and research organizations now collaborating on developing standard parallel programming model

November 12, 2018
·
2 min read
Business

Episciences, Inc. Announces New Manufacturing Facility

Episciences, Inc., maker of the renowned skincare brand Epionce, is proud to announce the grand opening of their new manufacturing facility in Boise, Idaho.

November 12, 2018
·
2 min read
Business

Treace Medical Announces Enrollment of the First Patient in the ALIGN3D™ Post-Market Clinical Study of Lapiplasty® 3D Bunion Correction™

Multicenter prospective study aims to validate long-term maintenance of 3-dimensional correction following early return to weight-bearing

November 12, 2018
·
3 min read
Mallinckrodt To Present At 2018 BMO Prescriptions For Success Healthcare Conference

Mallinckrodt Pharmaceuticals will present on Wednesday, Dec. 12, 2018, at the BMO Prescriptions for Success Healthcare Conference at the Mandarin Oriental, 80 Columbus Circle, New York.

November 12, 2018
·
2 min read
Biotech Bay

Gilead Sciences to Present at the Evercore ISI HealthCONx Conference on Tuesday, November 27

Webcast Available Through Gilead Corporate Website

November 12, 2018
·
1 min read
Genetown

Mersana Therapeutics Presents Pre-clinical Data at AACR-NCI-EORTC on Two Additional, Proprietary Antibody Drug Conjugate Platforms and a Pre-clinical Update for XMT-1522 in Non-small Cell Lung Cancer

Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs) based on its Dolaflexin® and other proprietary platforms, today announced it will present data on two new, novel antibody-drug conjugate (ADC) platforms at the AACR-NCI-EORTC International Conference

November 12, 2018
·
4 min read